Geisinger Wyoming Valley Medical Center introduces CyberKnife robotic radiosurgery treatment system
Anand Mahadevan, M.D., director of Geisinger’s radiation oncology program, discusses the CyberKnife technology now available at Geisinger Wyoming Valley Medical Center.
Frank M. and Dorothea Henry Cancer Center first in country to offer CyberKnife S7 system
The Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley is the first treatment center in the U.S. to offer CyberKnife robotic radiosurgery’s newest S7 technology.
“For nearly three decades we have been building a world-class cancer program in the community,” said Rajiv Panikkar, M.D., chair of Geisinger’s Cancer Institute. “Bringing this advanced treatment tool to Geisinger Wyoming Valley Medical Center makes it easier for our neighbors to receive innovative cancer care close to home.”
This news dovetails with Geisinger’s recent announcement to expand the Henry Cancer Center through an $80 million construction project.
The CyberKnife system offers non-invasive treatment for tumors that are hard to reach or inoperable by safely directing high doses of targeted radiation at those complex tumors anywhere in the body. A robotic arm focuses the radiation on the cancer, while avoiding the surrounding tissue. CyberKnife can be used for tumors of the prostate, lung, brain, spine, pancreas, kidney, breast and other conditions determined by the medical staff.
The S7 version of the technology works nearly twice as fast as previous CyberKnife models, building treatment plans in a few minutes, compared to a few hours. The system also offers personalized treatment plans by calculating multiple care options based on a patient’s body so all possibilities can be explored.
“This is an investment in the health of our communities,” said Anand Mahadevan, M.D., director of Geisinger’s radiation oncology program. “We’ve brought the latest CyberKnife technology to northeastern Pennsylvania so we can offer the most advanced and better treatment in our community. This is yet another advancement we’ve made since the Henry Cancer Center opened in 1992.”
The CyberKnife addition will bolster a growing list of advanced treatment and care options already provided by the Henry Cancer Center, including chemotherapy, infusion therapy, sophisticated imaging, comprehensive lab services, pharmacy services and research and clinical trials. This latest project also joins recent investments in a breast imaging center, focused laser imaging to target brain tumors, and TrueBeam radiation treatment.
CyberKnife will join growing services at the Henry Cancer Center in the coming years as Geisinger continues to bring innovative and advanced care options to Luzerne County.
Geisinger is set to start a 92,150-square-foot, four-story expansion project at the Henry Cancer Center later this year that will feature high-end care, including an 18-bed inpatient unit to serve bone marrow transplant patients, consolidation of treatment services and a redesigned reception and lounge area.
To learn more about how Geisinger is bringing advanced cancer care options to northeast and central Pennsylvania, visit geisinger.org/CyberKnifeNEPA.
About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.
